Pancreatic Cancer
📧 Sign up to get email alerts when something new happens for Pancreatic Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: PANCREATIC DISEASE COHORT A Registry and Biospecimen Bank to Better Understand Pancreatic Disease
A clinical trial registry for a Pancreatic Disease Cohort A Registry and Biospecimen Bank to better understand pancreatic disease, currently…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Support Through Remote Observation and Nutrition Guidance Program (STRONG-PCS) [NA]
The STRONG-PCS clinical trial update indicates a study sponsored by H. Lee Moffitt Cancer Center evaluating remote observation and nutrition…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Serum DCAMKL1 Pre and Post Treatment in Patients With Pancreatic Cancer
This clinical trial is studying serum DCAMKL1 levels before and after treatment in patients with pancreatic cancer; the study status is ACTI…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Longitudinal, Prospective, French, Multicenter Cohort Study on Pancreatic Radiofrequency
A longitudinal, prospective multicenter cohort study in France evaluating pancreatic tumor treatment using radiofrequency; the study is curr…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Lanreotide Versus Placebo Before Surgery to Prevent a Surgical Complication Called a Pancreatic Fistula [Phase 3]
A Phase 3 trial is evaluating lanreotide versus placebo given before pancreatic surgery to reduce the risk of pancreatic fistula.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Hepatic Arterial Infusion of Sodium Bicarbonate (NaHCO3) Combined With NASOX Regimen and Programmed Death-1 (PD-1) Inhibitors for Pancreatic Cancer Liver Metastases [Phase 2]
Phase 2 clinical trial assessing hepatic arterial infusion of sodium bicarbonate combined with the NASOX regimen and PD-1 inhibitors for pan…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Profiling Program of Advanced/Metastatic Pancreatic Cancer Patients [NA]
A profiling program study for advanced or metastatic pancreatic cancer is currently recruiting at Centre Léon Bérard.
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103) [Phase 1]
This is a Phase 1 trial evaluating Anvumetostat in combination with other therapies for advanced gastrointestinal, biliary tract, or pancrea…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: DESTINY-PANTUMOUR04
Clinical trial update for the DESTINY-PANTUMOUR04 study sponsored by AstraZeneca, evaluating trastuzumab deruxtecan across multiple cancer t…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: The MONITOR Study: Remote Monitoring Of a Nutrition Intervention To Optimize Treatment Response [NA]
This document notes an ongoing clinical trial, the MONITOR Study, evaluating remote nutrition monitoring to optimize treatment response in p…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy
This clinical trial update describes the systematic assessment of hereditary pancreatic cancer risk and its implications for personalized th…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Phase IB Study to Determine the Safety and Tolerability of Canakinumab and Tislelizumab in Combination With Nab-Paclitaxel and Gemcitabine in the Neo-adjuvant Treatment of Patients With Pancreatic Cancer [Phase 1]
Phase 1B study assessing safety and tolerability of combining canakinumab and tislelizumab with nab-paclitaxel and gemcitabine as neoadjuvan…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study to Assess an ATX Inhibitor (IOA-289) in Patients With Metastatic Pancreatic Cancer [Phase 1, Phase 2]
This entry documents the completion of a Phase 1/2 clinical trial evaluating IOA-289, an ATX inhibitor from iOnctura, in patients with metas…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue [NA]
A Memorial Sloan Kettering Cancer Center trial evaluating radiation therapy for solid tumors that have metastasized to soft tissue. The stud…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Immunoparalysis After Pancreaticoduodenectomy
An ongoing clinical trial in Lyon is recruiting to study immunoparalysis after pancreaticoduodenectomy in patients with pancreatic ductal ad…
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2)
Clinical Trial Update: Cancer Loyalty Card Study 2 (CLOCS-2) from Imperial College London indicates the study is currently recruiting for mu…
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma (VAPOR2)
A recruiting clinical trial (VAPOR2) led by Imperial College London studying volatile organic compound assessment in pancreatic cancer/PDAC.
-
CLINICAL_TRIALS research · 2026-03-24Clinical Trial Update: Volatile Organic Compound Assessment in Pancreatic Ductal Adenocarcinoma
Clinical trial update indicating a study evaluating volatile organic compound assessment in pancreatic ductal adenocarcinoma is currently re…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Surveillance of Pancreatic Health After Diabetes Diagnosis [NA]
A recruiting clinical trial sponsored by University Hospital Southampton NHS Foundation Trust to surveil pancreatic health after a diagnosis…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Two Methods to Follow Patients With Pancreatic Cysts [NA]
This clinical trial update reports on a study comparing two methods to follow patients with pancreatic cancer. The trial is currently active…
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Evaluation of Endoscopic Ultrasound-Guided Radiofrequency Ablation for the Management of Pancreatic Tumors, ERASE Study [NA]
This clinical trial is evaluating endoscopic ultrasound-guided radiofrequency ablation for pancreatic tumors and is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-23Clinical Trial Update: Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread [Phase 2]
Phase 2 trial update evaluating two regimens for older patients with metastatic pancreatic cancer: gemcitabine plus nab-paclitaxel versus a …
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors [Phase 1]
A Phase 1 first-in-human study of IPH5301, an anti-CD73 antibody, given alone or with chemotherapy and trastuzumab, in patients with advance…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Radiotherapy for Locally Advanced Pancreatic Carcinomas (Phase II Trial) [NA]
A Phase II clinical trial evaluating radiotherapy for locally advanced pancreatic cancer is currently recruiting. No results are reported ye…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Evaluation of Resection Techniques for Pancreatic Tumors
A study evaluating surgical resection techniques for pancreatic tumors is currently recruiting, sponsored by Methodist Health System.